Surrozen, Inc./DE
Develops drug candidates to selectively modulate the Wnt pathway for tissue repair.
SRZN | US
Overview
Corporate Details
- ISIN(s):
- KYG2445M1033 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 171 OYSTER POINT BLVD, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.surrozen.com
Description
Surrozen, Inc. is a clinical-stage company that discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is pioneering a new class of targeted regenerative antibodies designed to stimulate the body's own repair mechanisms. These therapeutics aim to repair a broad range of tissues and restore organs damaged by serious diseases and injuries, with the goal of unlocking the body's regenerative power.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Surrozen, Inc./DE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Surrozen, Inc./DE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Surrozen, Inc./DE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
